Related Experiment Video

Updated: Jun 24, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer

Patrick G Morris1, Monica N Fornier

  • 1Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

Clinical Advances in Hematology & Oncology : H&O
|April 16, 2009
PubMed

Insights

Epothilones offer a promising alternative to taxanes for cancer treatment, demonstrating efficacy against resistant tumors. Ixabepilone, an epothilone, is FDA-approved for metastatic breast cancer, though neuropathy remains a concern.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Taxanes are crucial cytotoxic agents for cancer treatment but face limitations like tumor resistance and toxicity.
  • Epothilones, microtubule-targeting macrolide antibiotics, present a novel therapeutic avenue.
  • Epothilones show potential to overcome taxane resistance and associated toxicities.

Purpose of the Study:

  • To review the efficacy and limitations of taxanes in cancer therapy.
  • To introduce epothilones as a potential alternative to taxanes.
  • To discuss the clinical development and therapeutic potential of epothilones, including ixabepilone.

Main Methods:

  • Literature review of taxane and epothilone efficacy and toxicity.
  • Analysis of clinical trial data for ixabepilone.
  • Comparison of mechanisms of action and resistance profiles.

Main Results:

  • Taxanes are effective but limited by resistance and toxicity (neurotoxicity, myelosuppression).
  • Epothilones demonstrate activity against taxane-resistant tumors.
  • Ixabepilone is approved for metastatic breast cancer, with peripheral neuropathy as a dose-limiting toxicity.

Conclusions:

  • Epothilones represent a significant advancement in cancer chemotherapy, offering an alternative for resistant malignancies.
  • Ixabepilone's clinical success warrants further investigation in other cancers and settings.
  • Continued research into epothilones is crucial for expanding their role in oncology.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...